Comparison of depressive, anxiety and somatization symptoms in patients with chronic myeloproliferative neoplasms treated with interferon alpha and tyrosine kinase inhibitors

Preview format:

Object preview unavailable

We use files, through the cookie quality improvement layer of our website.For more information, please read the document